Clients

  • 3M
  • acQuire Technologies
  • Acrux
  • Advanced Medical Optics
  • Aetna
  • AIG
  • Alcan Packaging
  • Alstom
  • American Medical Systems
  • Amway
  • Assurant
  • Atral
  • Attenex
  • Australia Post
  • Australian Pacific Touring
  • Baloise Bank SoBa
  • Bayer CropScience
  • BD Medical
  • Bosch
  • Boston Scientific
  • California Healthcare Foundation
  • Cargill
  • Centre de Recherche Industrielle du Quebec
  • Ceridian
  • Chiquita
  • Cintas
  • Cochlear
  • Colgate-Palmolive
  • Coloplast
  • Comprehensive Loyalty, Inc.
  • Continental Automated Buildings Association
  • Covidien
  • Dell Inc.
  • Deltec
  • Dentsply
  • DSM
  • Ecolab
  • Elkay Manufacturing
  • elsevier
  • ESRI (UK)
  • Ethicon-Endo Surgery
  • Fresenius Medical Care
  • Garlock
  • GE Money
  • Guidant
  • H&R Block
  • Hager Electro GmbH
  • Hallmark Cards
  • Harvard University
  • Hewlett Packard
  • Hills Pet
  • Hollister
  • Hospira
  • IBM
  • Incitec Pivot Limited
  • Ingersoll Rand
  • Intuit
  • Isodis Natura
  • Johnson & Johnson
  • J.R. Simplot Company
  • John Deere
  • Karl Storz Endoscopes
  • Kimberly-Clark Health Care
  • Kroll Ontrack
  • Lexmark
  • Liebherr
  • Line 6
  • Masco Corporation
  • Mead Johnson Nutritionals
  • Mead Westvaco
  • Medtronic
  • MetLife
  • Microsoft
  • Motorola
  • MYOB
  • Neenah Paper
  • New Pig Corporation
  • NFPA
  • Nortel Networks
  • Pershing LLC
  • Picanol
  • Powercor
  • QFD Institute
  • R.H. Donnelley
  • Research In Motion (RIM)
  • ResMed
  • Reynolds & Reynolds
  • Roche Diagnostics
  • Rockwell Collins
  • Rohm & Haas
  • Sabre Holdings
  • Selecta
  • SHRM
  • State Farm
  • Swiss-Coffee-Concept
  • Syngenta
  • Tektronix
  • Toronto Dominion Bank (TD)
  • Townsend Inc.
  • Trane
  • Trend Micro
  • Unilever
  • Vtech
  • Washington Mutual
  • WellPoint, Inc.
  • Zassi Medical Evolutions

General Motors

“We hired Strategyn to help us identify with precision where the opportunities for value creation lie in particular markets of interest ... We are very excited about the results ODI will deliver and we have high hopes that it will play an important role in helping us make vehicles that customers want to buy.”

William J. Rosen

Cordis (j&j)

"Using this approach, we reprioritized resources so we could be the first to market with the stent, an opportunity that became a $1 billion product in less than two years -- the fastest growing medical device in history."

Rick Faleschini

Kroll

"Using the six growth path framework, our team was able to pinpoint exactly where an acquisition target fit into our overall market strategy. Knowing where it fit and what needs the company could help us potentially address, we were able to make an informed M&A decision."

Ben Allen

FREE DOWNLOAD - Giving Customers a Fair Hearing

FREE DOWNLOAD - Giving Customers a Fair Hearing

Learn more about Outcome-Driven Innovation by downloading our articles published in MIT Sloan Management Review.

Read More >